Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Novartis Q1 2024 Adj EPS $1.80 Beats $1.67 Estimate, Sales $11.829B Beat $11.433B Estimate

Author: Benzinga Newsdesk | April 23, 2024 02:28am
Novartis (NYSE:NVS) reported quarterly earnings of $1.80 per share which beat the analyst consensus estimate of $1.67 by 7.78 percent. This is a 16.88 percent increase over earnings of $1.54 per share from the same period last year. The company reported quarterly sales of $11.829 billion which beat the analyst consensus estimate of $11.433 billion by 3.46 percent. This is a 8.68 percent decrease over sales of $12.953 billion the same period last year.

Posted In: NVS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist